Breast conserving therapy for central breast cancer in the United States.

BMC Surg · 2022 · PMC8800313 · PMID 35090409

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Figure 1 showed a trend of BCT for T1-4 central breast cancer and the BCT rate (51%) exceeded non-BCT in 2015.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.